| Item Type | Name |
|
Academic Article
|
RNA oxidation in Alzheimer disease and related neurodegenerative disorders.
|
|
Academic Article
|
Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulation.
|
|
Academic Article
|
Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta.
|
|
Academic Article
|
Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment.
|
|
Academic Article
|
Divalent metal transporter, iron, and Parkinson's disease: a pathological relationship.
|
|
Academic Article
|
Elevation of {beta}-amyloid 1-42 autoantibodies in the blood of amnestic patients with mild cognitive impairment.
|
|
Academic Article
|
Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease.
|
|
Academic Article
|
Oxidative damage to RNA in aging and neurodegenerative disorders.
|
|
Academic Article
|
DNA damage in Alzheimer disease lymphocytes and its relation to premature centromere division.
|
|
Academic Article
|
A clinical study of lupron depot in the treatment of women with Alzheimer's disease: preservation of cognitive function in patients taking an acetylcholinesterase inhibitor and treated with high dose lupron over 48 weeks.
|
|
Academic Article
|
The complexities of the pathology-pathogenesis relationship in Alzheimer disease.
|
|
Academic Article
|
From Neurodegeneration to Brain Health: An Integrated Approach.
|
|
Academic Article
|
Insights into the structural patterns of the antileishmanial activity of bi- and tricyclic N-heterocycles.
|
|
Academic Article
|
Functional and Genomic Features of Human Genes Mutated in Neuropsychiatric Disorders.
|
|
Academic Article
|
Rosmarinic acid prevents fibrillization and diminishes vibrational modes associated to ? sheet in tau protein linked to Alzheimer's disease.
|
|
Academic Article
|
Inhibition of mitochondrial fragmentation protects against Alzheimer's disease in rodent model.
|
|
Academic Article
|
Drug-Abuse Nanotechnology: Opportunities and Challenges.
|
|
Academic Article
|
Consequences of RNA oxidation on protein synthesis rate and fidelity: implications for the pathophysiology of neuropsychiatric disorders.
|
|
Academic Article
|
The Need to Separate Chronic Traumatic Encephalopathy Neuropathology from Clinical Features.
|
|
Academic Article
|
No Evidence of Increased Chronic Traumatic Encephalopathy Pathology or Neurodegenerative Proteinopathy in Former Military Service Members: A Preliminary Study.
|
|
Academic Article
|
Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders.
|
|
Academic Article
|
TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease.
|
|
Academic Article
|
High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal.
|
|
Academic Article
|
Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice.
|
|
Academic Article
|
Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
|
|
Academic Article
|
Is nitric oxide a key target in the pathogenesis of brain lesions during the development of Alzheimer's disease?
|
|
Academic Article
|
The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications.
|
|
Academic Article
|
Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease.
|
|
Academic Article
|
Amyloid-beta-induced toxicity of primary neurons is dependent upon differentiation-associated increases in tau and cyclin-dependent kinase 5 expression.
|
|
Academic Article
|
Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition.
|
|
Academic Article
|
Neurotoxic dopamine quinone facilitates the assembly of tau into fibrillar polymers.
|
|
Academic Article
|
Nanoparticle iron chelators: a new therapeutic approach in Alzheimer disease and other neurologic disorders associated with trace metal imbalance.
|
|
Academic Article
|
Increases in luteinizing hormone are associated with declines in cognitive performance.
|
|
Academic Article
|
Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease.
|
|
Academic Article
|
Alzheimer's disease: cerebrovascular dysfunction, oxidative stress, and advanced clinical therapies.
|
|
Academic Article
|
The neuronal expression of MYC causes a neurodegenerative phenotype in a novel transgenic mouse.
|
|
Academic Article
|
Nanoparticle-chelator conjugates as inhibitors of amyloid-beta aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer disease.
|
|
Academic Article
|
Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts.
|
|
Academic Article
|
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes.
|
|
Academic Article
|
Evidence for the novel expression of human kallikrein-related peptidase 3, prostate-specific antigen, in the brain.
|
|
Concept
|
Abnormalities, Multiple
|
|
Concept
|
Alzheimer Disease
|
|
Concept
|
Amnesia
|
|
Concept
|
Amyloidosis
|
|
Concept
|
Amyotrophic Lateral Sclerosis
|
|
Concept
|
Aneuploidy
|
|
Concept
|
Aortic Diseases
|
|
Concept
|
Arteriosclerosis
|
|
Concept
|
Arthritis, Rheumatoid
|
|
Concept
|
Asphyxia Neonatorum
|
|
Concept
|
Asthma
|
|
Concept
|
Astrocytoma
|
|
Concept
|
Atrophy
|
|
Concept
|
Autistic Disorder
|
|
Concept
|
Mental Disorders
|
|
Concept
|
Behavioral Symptoms
|
|
Concept
|
Brain Concussion
|
|
Concept
|
Brain Diseases
|
|
Concept
|
Brain Diseases, Metabolic
|
|
Concept
|
Brain Edema
|
|
Concept
|
Brain Injuries
|
|
Concept
|
Brain Neoplasms
|
|
Concept
|
Breast Neoplasms
|
|
Concept
|
Cardiovascular Diseases
|
|
Concept
|
Central Nervous System Diseases
|
|
Concept
|
Hypoxia, Brain
|
|
Concept
|
Cerebral Hemorrhage
|
|
Concept
|
Brain Ischemia
|
|
Concept
|
Ischemic Attack, Transient
|
|
Concept
|
Cerebrovascular Disorders
|
|
Concept
|
Chlamydia Infections
|
|
Concept
|
Chronic Disease
|
|
Concept
|
Cognition Disorders
|
|
Concept
|
Communicable Diseases
|
|
Concept
|
Dementia
|
|
Concept
|
Demyelinating Diseases
|
|
Concept
|
Depression, Chemical
|
|
Concept
|
Depressive Disorder, Major
|
|
Concept
|
Diabetes Mellitus
|
|
Concept
|
Diabetes Mellitus, Experimental
|
|
Concept
|
Diabetes Mellitus, Type 1
|
|
Concept
|
Diabetes Mellitus, Type 2
|
|
Concept
|
Diabetic Retinopathy
|
|
Concept
|
Disease Models, Animal
|
|
Concept
|
DNA Damage
|
|
Concept
|
Dose-Response Relationship, Drug
|
|
Concept
|
Down Syndrome
|
|
Concept
|
Edema
|
|
Concept
|
Encephalitis
|
|
Concept
|
Encephalomyelitis, Autoimmune, Experimental
|
|
Concept
|
Erythroblastosis, Fetal
|
|
Concept
|
Eye Diseases
|
|
Concept
|
Food Deprivation
|
|
Concept
|
Gait
|
|
Concept
|
Genetic Markers
|
|
Concept
|
Glaucoma
|
|
Concept
|
Glioblastoma
|
|
Concept
|
Glioma
|
|
Concept
|
Gliosis
|
|
Concept
|
Goiter, Nodular
|
|
Concept
|
Huntington Disease
|
|
Concept
|
Hydrocephalus
|
|
Concept
|
Hypercholesterolemia
|
|
Concept
|
Hyperlipoproteinemia Type II
|
|
Concept
|
Hyperinsulinism
|
|
Concept
|
Hyperlipidemias
|
|
Concept
|
Hypothyroidism
|
|
Concept
|
Inflammation
|
|
Concept
|
Insulin Resistance
|
|
Concept
|
Interpersonal Relations
|
|
Concept
|
Ischemia
|
|
Concept
|
Creutzfeldt-Jakob Syndrome
|
|
Concept
|
Leigh Disease
|
|
Concept
|
Life Style
|
|
Concept
|
Liver Neoplasms
|
|
Concept
|
Lymphoma
|
|
Concept
|
Mammary Neoplasms, Experimental
|
|
Concept
|
Memory Disorders
|
|
Concept
|
Meningitis
|
|
Concept
|
Metabolic Diseases
|
|
Concept
|
Metal Metabolism, Inborn Errors
|
|
Concept
|
Movement Disorders
|
|
Concept
|
Multiple Sclerosis
|
|
Concept
|
Muscular Atrophy
|
|
Concept
|
Muscular Diseases
|
|
Concept
|
Muscular Dystrophies
|
|
Concept
|
Muscular Dystrophy, Animal
|
|
Concept
|
Myositis
|
|
Concept
|
Opioid-Related Disorders
|
|
Concept
|
Necrosis
|
|
Concept
|
Neoplasm Metastasis
|
|
Concept
|
Neoplasms
|
|
Concept
|
Nerve Degeneration
|
|
Concept
|
Nervous System Diseases
|
|
Concept
|
Neuritis
|
|
Concept
|
Neuroblastoma
|
|
Concept
|
Obesity
|
|
Concept
|
Oligodendroglioma
|
|
Concept
|
Optic Nerve Diseases
|
|
Concept
|
Parkinson Disease
|
|
Concept
|
Parkinson Disease, Secondary
|
|
Concept
|
Pharyngeal Diseases
|
|
Concept
|
Pneumonia, Viral
|
|
Concept
|
Postmortem Changes
|
|
Concept
|
Prediabetic State
|
|
Concept
|
Prostatic Neoplasms
|
|
Concept
|
Protein Denaturation
|
|
Concept
|
Retinal Diseases
|
|
Concept
|
Retrograde Degeneration
|
|
Concept
|
Scrapie
|
|
Concept
|
Spinal Cord Diseases
|
|
Concept
|
Stress, Psychological
|
|
Concept
|
Structure-Activity Relationship
|
|
Concept
|
Subacute Sclerosing Panencephalitis
|
|
Concept
|
Supranuclear Palsy, Progressive
|
|
Concept
|
Syndrome
|
|
Concept
|
Tremor
|
|
Concept
|
Vitamin D Deficiency
|
|
Concept
|
Wiskott-Aldrich Syndrome
|
|
Concept
|
Dementia, Vascular
|
|
Concept
|
Colorectal Neoplasms
|
|
Concept
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
|
|
Concept
|
Cerebral Amyloid Angiopathy
|
|
Concept
|
Malaria, Cerebral
|
|
Concept
|
Neurofibrillary Tangles
|
|
Concept
|
Prion Diseases
|
|
Concept
|
Sequence Deletion
|
|
Concept
|
Age of Onset
|
|
Concept
|
Fatal Outcome
|
|
Concept
|
Coronavirus Infections
|
|
Concept
|
Oxidative Stress
|
|
Concept
|
Pneumonia, Bacterial
|
|
Concept
|
Myositis, Inclusion Body
|
|
Concept
|
Iron Metabolism Disorders
|
|
Concept
|
Iron Overload
|
|
Concept
|
Xanthomatosis, Cerebrotendinous
|
|
Concept
|
Multiple System Atrophy
|
|
Concept
|
Neurodegenerative Diseases
|
|
Concept
|
Substance-Related Disorders
|
|
Concept
|
Recovery of Function
|
|
Concept
|
Brain Injury, Chronic
|
|
Concept
|
Gait Disorders, Neurologic
|
|
Concept
|
Infarction, Middle Cerebral Artery
|
|
Concept
|
Neurotoxicity Syndromes
|
|
Concept
|
Heredodegenerative Disorders, Nervous System
|
|
Concept
|
Intracranial Hemorrhages
|
|
Concept
|
Stroke
|
|
Concept
|
Brain Diseases, Metabolic, Inborn
|
|
Concept
|
Pick Disease of the Brain
|
|
Concept
|
Hypoxia-Ischemia, Brain
|
|
Concept
|
Lewy Body Disease
|
|
Concept
|
Tauopathies
|
|
Concept
|
Cerebral Amyloid Angiopathy, Familial
|
|
Concept
|
Mitochondrial Diseases
|
|
Concept
|
Post-Concussion Syndrome
|
|
Concept
|
Diabetes Complications
|
|
Concept
|
Atherosclerosis
|
|
Concept
|
DNA Degradation, Necrotic
|
|
Concept
|
TDP-43 Proteinopathies
|
|
Concept
|
Frontotemporal Dementia
|
|
Academic Article
|
What is aging? What is its role in Alzheimer's disease? What can we do about it?
|
|
Academic Article
|
?-amyloid 1-42 induces physiological transcriptional regulation of BACE1.
|
|
Academic Article
|
Analysis of the Relationship Between Metalloprotease-9 and Tau Protein in Alzheimer's Disease.
|
|
Academic Article
|
Gait Disorders in Alzheimer's Disease and Other Dementias: There is Something in the Way You Walk.
|
|
Academic Article
|
Serial reconstruction of beta-protein amyloid plaques: relationship to microvessels and size distribution.
|
|
Academic Article
|
Demonstration of a novel neurofilament associated antigen with the neurofibrillary pathology of Alzheimer and related diseases.
|
|
Academic Article
|
Impaired motility of neonatal PMN leukocytes: relationship to abnormalities of cell orientation and assembly of microtubules in chemotactic gradients.
|
|
Academic Article
|
Widespread serum amyloid P immunoreactivity in cortical amyloid deposits and the neurofibrillary pathology of Alzheimer's disease and other degenerative disorders.
|
|
Academic Article
|
The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease.
|
|
Academic Article
|
Neurochemistry of dementia: establishing the links.
|
|
Academic Article
|
The amyloid precursor protein in ischemic brain injury and chronic hypoperfusion.
|
|
Academic Article
|
Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease.
|
|
Academic Article
|
Cerebrovascular muscle atrophy is a feature of Alzheimer's disease.
|
|
Academic Article
|
In situ methods for detection and localization of markers of oxidative stress: application in neurodegenerative disorders.
|
|
Academic Article
|
Melatonin reduces interleukin secretion in amyloid-beta stressed mouse brain slices.
|
|
Academic Article
|
Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation.
|
|
Academic Article
|
Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease.
|
|
Academic Article
|
Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4-hydroxy-2-nonenal.
|
|
Academic Article
|
The effect of agonists and antagonists on the morphology of non-transformed human smooth muscle cell in vitro.
|
|
Academic Article
|
Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy.
|
|
Academic Article
|
The mitochondrial common deletion in Parkinson's disease and related movement disorders.
|
|
Academic Article
|
Retinoic acid isomers protect hippocampal neurons from amyloid-beta induced neurodegeneration.
|
|
Academic Article
|
Prospects on the origin of Alzheimer's disease.
|
|
Academic Article
|
Global warming and neurodegenerative disorders: speculations on their linkage.
|
|
Academic Article
|
Transplantation of Human Chorion-Derived Cholinergic Progenitor Cells: a Novel Treatment for Neurological Disorders.
|
|
Academic Article
|
Correction to: Transplantation of Human Chorion-Derived Cholinergic Progenitor Cells: a Novel Treatment for Neurological Disorders.
|
|
Grant
|
AMYLOID PRECURSOR IN ALZHEIMER DISEASE
|
|
Academic Article
|
An integrative skeletal and paleogenomic analysis of stature variation suggests relatively reduced health for early European farmers.
|
|
Academic Article
|
Hyperphosphorylated Tau Relates to Improved Cognitive Performance and Reduced Hippocampal Excitability in the Young rTg4510 Mouse Model of Tauopathy.
|
|
Academic Article
|
Natural Product Co-Metabolism and the Microbiota-Gut-Brain Axis in Age-Related Diseases.
|
|
Academic Article
|
Optogenetics: implications for Alzheimer's disease research and therapy.
|
|
Academic Article
|
SWADESH: A Comprehensive Platform for Multimodal Data and Analytics for Advanced Research in Alzheimer's Disease and Other Brain Disorders.
|
|
Academic Article
|
Neuropathologic Changes Provide Insights into Key Mechanisms of Alzheimer Disease and Related Dementia.
|
|
Academic Article
|
Gene Co-Expression Analysis of Multiple Brain Tissues Reveals Correlation of FAM222A Expression with Multiple Alzheimer's Disease-Related Genes.
|
|
Academic Article
|
MRI Monitoring of Anti-Alzheimer Therapy Amyloid-Related Imaging Abnormalities: Due Diligence or Overkill?
|